Racial differences in the cause-specific prevalence of blindness in east baltimore

New England Journal of Medicine

Volumn 325, Issue 20, 1991, Pages 1412-1417

  Sommer, Alfred ^a   Tielsch, James M ^a   Katz, Joanne ^a   Quigley, Harry A ^a   Gottsch, John D ^a   Javitt, Jonathan C ^a   Martone, James F ^a   Royall, Richard M ^b   Witt, Kathe A ^a   Ezrine, Sandi ^c  

^a JOHNS HOPKINS UNIVERSITY   (United States)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^c Survey Research Associates Inc ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE; AGED; ARTICLE; BLINDNESS; CATARACT; ETHNIC DIFFERENCE; HUMAN; MAJOR CLINICAL STUDY; OPEN ANGLE GLAUCOMA; PREVALENCE; PRIORITY JOURNAL; RETINA MACULA DEGENERATION; SCREENING; UNITED STATES; URBAN AREA;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; BALTIMORE; BLACKS; BLINDNESS; CATARACT; CLUSTER ANALYSIS; ETHNIC GROUPS; GLAUCOMA, OPEN-ANGLE; HEALTH SERVICES; HUMAN; MACULAR DEGENERATION; MIDDLE AGE; PREVALENCE; RACIAL STOCKS; SUPPORT, U.S. GOV'T, P.H.S.; URBAN POPULATION; WHITES;

EID: 0026046014     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJM199111143252004     Document Type: Article

References (28)

1. Goldstein H. The demography of blindness throughout the world. New York: American Foundation for the Blind, 1980. (Research series no. 26.)
2. National Society to Prevent Blindness. Vision problems in the United States. New York: National Society to Prevent Blindness, 1980.
3. National Advisory Eye Council. Vision research: a national plan: 1983. Bethesda, Md.: Department of Health and Human Services, 1983:12–4. (NIH publication no. 83–2469.)
4. Kirchner C, Peterson R. The latest data on visual disability from NCHS. Visual Impairment Blindness 1979; 73: 151–3.
5. Kahn HA, Moorhead HB. Statistics on blindness in the model reporting area 1969–1970. Washington, D.C.: National Eye Institute, 1973. (DHEW publication no. (NIH) 73–427.)
6. Ganley JP, Roberts J. Eye conditions and related need for medical care among persons 1–74 years of age, United States, 1971–72. Vital and health statistics. Series 11. No. 228. Washington, D.C.: Government Printing Office, 1983.
7. Leibowitz HM, Knieger DE, Maunder LR, et al. The Framingham eye study monograph. Surv Ophthalmol 1980; 24: Suppl: 335–610.
8. Tielsch JM, Sommer A, Witt K, Katz J, Royall RM. Blindness and visual impairment in an American urban population: the Baltimore Eye Survey. Arch Ophthalmol 1990: 108: 286–90.
9. Tielsch JM, Sommer A, Katz J, Royall RM, Quigley HA, Javitt J. Racial variations in the prevalence of primary open-angle glaucoma: the Baltimore Eye Survey. JAMA 1991; 266: 369–74.
10. Tielsch JM, Sommer A, Katz J, Quigley H, Ezrine S. Socioeconomic status and visual impairment among urban Americans. Arch Ophthalmol 1991; 109: 637–41.
11. Ferris FL III, Sperduto RD. Standardized illumination for visual acuity testing in clinical research. Am J Ophthalmol 1982; 94: 97–8.
12. Kosoko O, Sommer A, Auer C. Screening with automated perimetry using a threshold-related three-level algorithm. Ophthalmology 1986; 93: 882–6.
13. Sommer A, Quigley HA, Robin AL, Miller NR, Katz J, Arkell S. Evaluation of nerve fiber layer assessment. Arch Ophthalmol 1984; 102: 1766–71.
14. Kahn HA, Sempos CT. Statistical methods in epidemiology. New York: Oxford University Press, 1989.
15. Pearson ES, Hartley HO, eds. Biometrika tables for statisticians. 2nd ed. Vol. 1. Cambridge, England: Cambridge University Press, 1958:203.
16. Taylor JM. Medicare payments and changes in the rate of cataract extraction. Ophthalmology 1981; 88: 41A–46A.
17. Sommer A. Cataracts as an epidemiologic problem. Am J Ophthalmol 1977; 83: 334–9.
18. Stark WJ, Sommer A, Smith RE. Changing trends in intraocular lens implantation. Arch Ophthalmol 1989; 107: 1441–4.
19. Cairns L, Sommer A. Changing indications for cataract surgery. Trans Am Ophthalmol Soc 1984; 82: 166–75.
20. Sommer A, Tielsch JM, Katz J, et al. Relationship between intraocular pressure and primary open angle glaucoma among white and black Americans: the Baltimore Eye Survey. Arch Ophthalmol 1991; 109: 1090–5.
21. Mason RP, Kosoko O, Wilson MR, et al. National survey of the prevalence and risk factors of glaucoma in St. Lucia, West Indies. Part I. Prevalence findings. Ophthalmology 1989; 96: 1363–8.
22. Martin MJ, Sommer A, Gold EB, Diamond EL. Race and primary openangle glaucoma. Am J Ophthalmol 1985; 99: 383–7.
23. Grant WM, Burke JF. Why do some people go blind from glaucoma? Ophthalmology 1982; 89: 991–8.
24. Wilson R, Richardson TM, Hertzmark E, Grant WM. Race as a risk factor for progressive glaucomatous damage. Ann Ophthalmol 1985; 17: 653–9.
25. The Diabetic Retinopathy Study Research Group. Photocoagulation treatment of proliferative diabetic retinopathy: clinical application of Diabetic Retinopathy Study (DRS) findings, DRS Report Number 8. Ophthalmology 1981; 88: 583–600.
26. Early Treatment Diabetic Retinopathy Study research group. Photocoagulation for diabetic macular edema. Early Treatment Diabetic Retinopathy Study report number 1. Arch Ophthalmol 1985; 103: 1796–806.
27. Javitt JC, Canner JK, Sommer A. Cost effectiveness of current approaches to the control of retinopathy in type I diabetes. Ophthalmology 1989; 96: 255–64.
28. Ederer S, Krueger DE, Mowery RL, Connett J, Wentworth D. Lessons from the Visual Acuity Impairment Survey pilot study. Am J Public Health 1986; 76: 160–5.